Galectin Therapeutics Reports March 31, 2026 Financial Results and Provides Business Update
Go back to Galectin Therapeutics Reports March 31, 2026 Financial Results and Provides Business Update| GALECTIN (NASDAQ: GALT) | Delayed: 2.67 +0.06 (2.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.61 | 52 Week High | $3.05 | |||
| Open | $2.61 | 52 Week Low | $0.49 | |||
| Day High | $2.76 | P/E | N/A | |||
| Day Low | $2.58 | EPS | $-1.32 | |||
| Volume | 282,138 | |||||

